ROGAINE
Pronunciation: mi-NOX-i-dil


What it isTopical KATP-channel opener that promotes follicular growth; androgenetic alopecia.
Why this oneThe famous side effect turned indication: the oral vasodilator's hypertrichosis, bottled. Follicular sulfotransferase activates it to minoxidil sulfate at the target.
What limits itInitial shedding, scalp irritation, and unwanted facial hair can end the trial; gains recede after discontinuation.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Regrow hair on top of scalp (vertex only) | Men ≥18 yr | 1 mL to scalp hair-loss area BID | 1 mL BID | 1 mL BID — using more or more often will not improve results |
Renal Undefined
Hepatic Undefined
Not intended for frontal baldness or receding hairline
Available strengths
Pregnancy May be harmful if used when pregnant (OTC warning)
Lactation May be harmful if used when breast-feeding (OTC warning)
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 2 % | sol | per unit | not offered | |
| 5 % | sol | per unit | not offered |
Other forms: Minoxidil oral (LONITEN)
NO BOXED WARNINGS
Principal riskSystemic absorption: stop for chest pain, rapid heartbeat or dizziness
Open Minoxidil topical in the interactive console ↗
